CARL DECICCO

Insider Reports History

Location
Cambridge, MA
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CARL DECICCO:

Company Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Scientific Officer Common Stock 362,707 $2,992,333 $8.25 09 Dec 2021 Direct
Foghorn Therapeutics Inc. Chief Scientific Officer Stock Options (Right to buy) 34,273 $104,875 $3.06 09 Dec 2021 Direct

Insider Reports Filed by CARL DECICCO

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FHTX Foghorn Therapeutics Inc. 09 Dec 2021 3 +$388,033 4 Chief Scientific Officer 13 Dec 2021, 19:37